Background: Candida auris was first described in 2009, and has since caused nosocomial outbreaks, invasive 18 infections and fungaemia across 11 countries in five continents. An outbreak of C. auris occurred in a 19 specialised cardiothoracic London hospital between April 2015 and November 2016, which to date has been the 20 largest outbreak reported worldwide, involving a total of 72 patients.
Introduction

36
The emerging fungal pathogen Candida auris causes nosocomial invasive infections, predominantly in intensive 37 care units (ICU). Since its first description in 2009 in Japan (1), reports of C. auris infections have been 38 reported in several countries (2-10). C. auris demonstrates intrinsic multidrug resistant (MDR) phenotype (9), 39 by exhibiting high level resistance to fluconazole and varying susceptibility to other azole drugs, amphotericin B 40 and a newly introduced class of antifungals, echinocandins (9).
42
In 2016, we described the first large-scale C. auris outbreak (April 2015 to November 2016) occurring within a 43 single specialist cardiothoracic hospital in London (6). Due to the high uncertainty as to the time and source of 44 introduction of C. auris into the hospital, the rapid development of a molecular epidemiological toolkit was 45 required. Outbreaks of other fungal pathogens have been previously investigated using short-read whole-46 genome sequencing (WGS), which provided sufficient information to discriminate between isolates and their 47 phylogenetic relationships using single nucleotide polymorphism (SNP) analysis (11) (12) (13) . Recently, the 48 handheld, portable MinION sequencer, manufactured by Oxford Nanopore Technologies, UK (ONT) has made 49 rapid WGS widely available in the field, and has been successfully used to analyse the molecular epidemiology 50 of recent Salmonella, and Ebola and Zika viruses outbreaks (14-16).
52 105
We assembled five high quality hybrid de novo reference genomes for C. auris using Illumina short-read 106 sequences and MinION long-read sequences rapidly generated over 48 hours. Five isolates (15B5, 16B21, 107 16B25, 16B20 and 16B15a) were chosen to cover a range of dates (October 2015 to March 2016). Isolate 16B25 108 had the best overall assembly quality of 110 contigs, N 50 = 396,317 bp and an estimated genome size of 12·3 Mb 109 (Table 3 and Supplementary Table S1 ). 98·94% of the 16B25 assembly mapped to the C. auris genome B8441 110 assembled by Lockhart and colleagues (9).
112
We generated an average of 5·2 million Illumina reads passing quality control for 27 isolates recovered during 113 the outbreak that mapped closely (average 95·5%) to our reference genome (Supplemental Material Table S2 ).
114
The rapid availability of long reads from MinION sequencing demonstrates this technology is ideally used in an 115 outbreak setting for providing high-quality contiguous assemblies. A total of 5,366 protein-coding genes, 4 116 rRNAs and 156 tRNAs were predicted using the genome annotation pipeline described in Supplementary 117 Methods. Table 3 summarises the general features of 16B25, along with other pathogenic Candida genomes.
118
The number of protein coding genes presented here is in line with the predicted number of genes in C. lusitaniae 119 (20) (n = 5,941), the closest known relative of C. auris.
121
There are fewer protein coding genes, tRNAs and rRNAs predicted in this genome than previously reported for 122 C. auris Ci 6684 in Chatterjee and colleagues (21), as shown in Table 3 . Running our annotation pipeline on the 123 B8441 isolate presented in Lockhart and colleagues (9) found similar numbers of protein coding genes, rRNAs 124 and tRNAs (Table 3) . Therefore, the different total numbers between 16B25 and Ci 6684 are likely due to the 125 different annotation pipelines and not the quality of the reference assemblies. The number of protein coding 126 genes identified in Chatterjee and colleagues is likely inflated due to over-prediction of short sequences, lack of 127 filtering of repetitive sequences, and using only GenemarkS to predict the start of genes; our pipeline used 128 additional criteria to achieve a predicted set of high-confidence genes.
130
Phylogenetic analysis reveals an Indian/Pakistani origin of C. auris outbreak 131 132
Phylogenetic analysis based on whole genome SNPs revealed the UK outbreak had an Indian/Pakistani origin 133 ( Figure 1 ). SNP calls for isolates from Venezuela, India, Pakistan, Japan and South Africa (9) were also 134 included to add geographic context to the outbreak. The UK outbreak isolates were in the same clade as those 135 from India and Pakistan (Figure 1a ); on average, 240 SNPs separated UK outbreak isolates from isolates 136 collected in India and Pakistan. There were no known patient travel links to India or Pakistan prior to admission 137 into hospital, however. We found an average of 84 SNPs separating isolates within the UK outbreak; later 138 isolates exhibited only 55 SNPs between them (October 2016), compared to earlier isolates (January 2016) that 139 showed an average 130 SNPs separating them.
141
Fitting root-to-tip regression showed there was a linear relationship between sampling time (days) and the 142 expected number of nucleotide substitutions along the tree, demonstrating clock-like evolution across the time- Overall, 14 isolates displayed MDR to two or more classes of antifungal drugs. Only five isolates displayed 154 resistance to one drug, fluconazole. All isolates expressed elevated levels of resistance to fluconazole (MIC: 155 >256 ug/ml), with varying levels of resistance to itraconazole (MIC: 0.03 ug/ml ->16 ug/ml), voriconazole (MIC: 0.12 ug/ml -8 ug/ml) and posaconazole (which has not been previously reported in C. auris). Four isolates also displayed resistance to amphotericin B (MIC: >2 ug/ml).
159
One isolate (16B15b) displayed elevated levels of resistance to all echinocandins (MIC: >8 ug/ml), but 160 remained susceptible to all azole drugs, with the exception to fluconazole. 16B15b also displayed high levels of 161 resistance to flucytosine (MIC >64 ug/ml), which was not seen in the other isolates; therefore, both mutations 162 and associated resistance were unique to this outbreak isolate. This isolate belonged to a patient who received 163 anidulafungin for 7 days for pancolitis, developing C. auris candidaemia 11 days afterwards, at which point 164 isolate 16B15a was recovered. Treatment was switched to amphotericin and 5-flucytosine for 2 weeks. Six days 165 after completing this treatment, a pan-resistant C. auris (16B15b) was recovered from the vascular tip. One non-166 synonymous SNP (nsSNP), causing a serine to tyrosine substitution (S652Y) was identified in the C. auris 167 FKS1 gene; a similar mutation (S645Y) in FKS1 has been associated with echinocandin resistance in C.
168 albicans (24). Another nsSNP caused a phenylalanine to isoleucine substitution (F211I) in FUR1, which has a 169 role in 5-flucytosine resistance (25). Neither of these mutations have been reported previously.
171
Orthologous sequences to C. albicans ERG11 were screened for substitutions that conferred known fluconazole 172 resistance mutations (19). The outbreak isolates all had the Y132F substitution in ERG11, confirming an 173 Indian/Pakistani origin. Lockhart and colleagues also found that these substitutions were strongly correlated 174 with geographic clades (9). Eight isolates within this study were sequential pairs of isolates from four separate patients (Table 1) ; we 201 hypothesised that there may have been nosocomial horizontal transmission between patients and/or their 202 surrounding environment, as suggested in previous studies (2,3,5,26), for the following pairs of isolates: 16B22a 203 and 16B22b from patient A (isolated 12 days apart); 16I27a (MICs were not carried out for this isolate) and
In patient A, 16B22a (recovered from the axilla) showed resistance to fluconazole only ( Table 2) 
244
A gold standard reference genome for the outbreak was assembled using long MinION-generated reads, and 245 Illumina short reads. Whilst the GC bias and base quality in >80% GC regions of the genome was similar in 246 both Illumina and MinION sequencing, Illumina was more consistent across the whole genome ( Figure S1 ).
247
MinION reads displayed wide variation in base quality in >85% AT regions, ranging from a quality score of 248 zero to 1·4, whereas Illumina reads ranged between quality scores of 0·75 and 0·85 for regions >85% AT. ONT 249 has since released new chemistry that improves read quality, and therefore the variant calling, which will 250 provide a competitive alternative to Illumina sequencing in both outbreak settings and routine research.
252
The speed of the MinION sequencer allowed rapid assembly and mapping of Illumina short reads to call high-
253
confidence SNPs, which is of great importance in an outbreak (14,15). SNPs in ERG11 correlated with known 
292
This study represents the first use of ONT MinION sequencer on a human fungal pathogen. The association of 293 nsSNPs in FKS1 and FUR1 with echinocandin and flucytosine resistance respectively are both clinically 294 relevant and novel. Further investigation into these mutations is required to confirm these associations.
295
Epidemiological analysis suggests that contact tracing was not sufficient to resolve fine-scale spatiotemporal 296 processes across the outbreak due to the multiple differential episodic selection occurring across a genetically 
